Pluri Inc. Debt Instrument, Interest Rate, Stated Percentage
Pluri Inc. (PLUR) had Debt Instrument, Interest Rate, Stated Percentage of 4.00% as of 2022-06-30, per its 10-K filed 2022-09-21.
Discontinued › Notes
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2022-09-21
- 2022-06-30: Debt Instrument, Interest Rate, Stated Percentage 4.00%.
- 2021-12-31: Debt Instrument, Interest Rate, Stated Percentage 4.00%.
- 2021-09-30: Debt Instrument, Interest Rate, Stated Percentage 4.00%.
- 2021-06-30: Debt Instrument, Interest Rate, Stated Percentage 4.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2022-06-30 | 4.00% 10-K · filed 2022-09-21 |
| 2021-12-31 | 4.00% 10-Q · filed 2022-02-07 |
| 2021-09-30 | 4.00% 10-Q · filed 2021-11-08 |
| 2021-06-30 | 4.00% 10-K · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |